2009
DOI: 10.1111/j.1473-2165.2009.00431.x
|View full text |Cite
|
Sign up to set email alerts
|

A lipohydroxyacid‐containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light‐to‐moderate scalp psoriasis

Abstract: This study not only allowed a better understanding of the SD and SP patient's profile but also demonstrated that the shampoo evaluated is a convenient, efficient, safe, and well-tolerated cosmetic treatment of SD and light-to-moderate SP improving greatly the quality of life of the treated patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 12 publications
1
5
0
Order By: Relevance
“…We have previously demonstrated that the LHA shampoo evaluated in this study improves scalp condition and quality of life in patients with SD and light to moderate scalp psoriasis 17 . This additional randomized double‐blind clinical study clearly confirmed the efficacy of the 0.1% LHA shampoo in the treatment of scalp SD.…”
Section: Discussionsupporting
confidence: 75%
“…We have previously demonstrated that the LHA shampoo evaluated in this study improves scalp condition and quality of life in patients with SD and light to moderate scalp psoriasis 17 . This additional randomized double‐blind clinical study clearly confirmed the efficacy of the 0.1% LHA shampoo in the treatment of scalp SD.…”
Section: Discussionsupporting
confidence: 75%
“…A self‐assessment of global QoL of the last 2 weeks was measured on a visual analog scale from 0 (good) to 10 (very bad). After the 3‐month treatment, the dermatologist and the parent gave their overall efficacy assessments, and the parent also evaluated improvement in health‐enhancing and quality of sleep of his or her child (five‐point scale from 0 [no improvement] to 4 [greater improvement]) and an overall safety assessment (five‐point scale from 0 (no tolerance or bad tolerance) to 4 (excellent tolerance)) of the investigational product (10).…”
Section: Methodsmentioning
confidence: 99%
“…The differential diagnosis of erythematous and desquamative scalp lesions may be challenging. Diseases such as psoriasis, seborrheic dermatitis, contact dermatitis, lichen planopilaris, tinea capitis, discoid lupus erythematosus, pemphigus foliaceus, pemphigus vulgaris, dermatomyositis, or syphilis present with similar clinical manifestations, most commonly as erythematous patches and scaling, often associated with pruritus [1][2][3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%